Sandra L. Deming

7.7k total citations · 1 hit paper
25 papers, 4.2k citations indexed

About

Sandra L. Deming is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Sandra L. Deming has authored 25 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Sandra L. Deming's work include BRCA gene mutations in cancer (5 papers), Cancer Risks and Factors (5 papers) and Global Cancer Incidence and Screening (4 papers). Sandra L. Deming is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Cancer Risks and Factors (5 papers) and Global Cancer Incidence and Screening (4 papers). Sandra L. Deming collaborates with scholars based in United States, China and India. Sandra L. Deming's co-authors include Patricia G. Moorman, H. Shelton Earp, Robert C. Millikan, David P. Cowan, Maggie C.U. Cheang, Torsten O. Nielsen, Kathleen Conway, Gamze Karaca, Chiu Kit Tse and Lisa A. Carey and has published in prestigious journals such as JAMA, Nature Genetics and The Journal of Cell Biology.

In The Last Decade

Sandra L. Deming

25 papers receiving 4.1k citations

Hit Papers

Race, Breast Cancer Subtypes, and Survival in the Carolin... 2006 2026 2012 2019 2006 500 1000 1.5k 2.0k 2.5k

Peers

Sandra L. Deming
Sharon N. Edmiston United States
Chiu Kit Tse United States
J.G.M. Klijn Netherlands
Sharon N. Edmiston United States
Sandra L. Deming
Citations per year, relative to Sandra L. Deming Sandra L. Deming (= 1×) peers Sharon N. Edmiston

Countries citing papers authored by Sandra L. Deming

Since Specialization
Citations

This map shows the geographic impact of Sandra L. Deming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra L. Deming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra L. Deming more than expected).

Fields of papers citing papers by Sandra L. Deming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra L. Deming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra L. Deming. The network helps show where Sandra L. Deming may publish in the future.

Co-authorship network of co-authors of Sandra L. Deming

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra L. Deming. A scholar is included among the top collaborators of Sandra L. Deming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra L. Deming. Sandra L. Deming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruiz-Narváez, Edward, Lara Sucheston‐Campbell, Jeannette T. Bensen, et al.. (2016). Admixture Mapping of African–American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes. Frontiers in Genetics. 7. 170–170. 16 indexed citations
2.
Dorjgochoo, Tsogzolmaa, Yong‐Bing Xiang, Jirong Long, et al.. (2013). Association of Genetic Markers in the BCL-2 Family of Apoptosis-Related Genes with Endometrial Cancer Risk in a Chinese Population. PLoS ONE. 8(4). e60915–e60915. 24 indexed citations
3.
Deming, Sandra L., Wei Lu, Alicia Beeghly‐Fadiel, et al.. (2011). Melatonin pathway genes and breast cancer risk among Chinese women. Breast Cancer Research and Treatment. 132(2). 693–699. 26 indexed citations
4.
Fu, Zhenming, Sandra L. Deming, Alecia M. Fair, et al.. (2011). Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study. Breast Cancer Research and Treatment. 129(3). 919–928. 38 indexed citations
5.
Bao, Ping‐Ping, Xiao Ou Shu, Yu‐Tang Gao, et al.. (2011). Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study. American Journal of Epidemiology. 174(6). 661–671. 74 indexed citations
6.
Deming, Sandra L., Jemimah Oduma, Muheez A. Durosinmi, et al.. (2010). Challenges Unique to the Design of a Comprehensive Questionnaire Assessing Breast Cancer Risk Factors Among Women in Sub-Saharan Africa. Journal of Health Care for the Poor and Underserved. 21(1A). 11–16. 3 indexed citations
7.
Deming, Sandra L., Yu‐Tang Gao, Jirong Long, et al.. (2009). Abstract #3945: Genetic variation in estrogen esterification pathway genes ACAA1, ACAA2, and LCAT and breast cancer risk. Cancer Research. 69. 3945–3945. 1 indexed citations
8.
Beeghly‐Fadiel, Alicia, Wei Lu, Yu‐Tang Gao, et al.. (2009). E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Breast Cancer Research and Treatment. 121(2). 445–452. 17 indexed citations
9.
Zheng, Wei, Jirong Long, Yu-Tang Gao, et al.. (2009). Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nature Genetics. 41(3). 324–328. 353 indexed citations
10.
Zheng, Wei, Qiuyin Cai, Lisa B. Signorello, et al.. (2009). Evaluation of 11 Breast Cancer Susceptibility Loci in African-American Women. Cancer Epidemiology Biomarkers & Prevention. 18(10). 2761–2764. 61 indexed citations
11.
Beeghly‐Fadiel, Alicia, Yong‐Bing Xiang, Sandra L. Deming, et al.. (2009). No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 18(6). 1925–1928. 8 indexed citations
12.
Hong, Young‐Seoub, Sandra L. Deming, Yu‐Tang Gao, et al.. (2009). A Two-stage Case-Control Study ofEGFRPolymorphisms and Breast Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 18(2). 680–683. 7 indexed citations
13.
Beeghly‐Fadiel, Alicia, Nobuhiko Kataoka, Xiao‐Ou Shu, et al.. (2008). Her-2/neu amplification and breast cancer survival: Results from the Shanghai breast cancer study. Oncology Reports. 19(5). 1347–54. 9 indexed citations
14.
Dorjgochoo, Tsogzolmaa, Sandra L. Deming, Yu‐Tang Gao, et al.. (2008). History of benign breast disease and risk of breast cancer among women in China: a case–control study. Cancer Causes & Control. 19(8). 819–828. 21 indexed citations
15.
Deming, Sandra L., Zefang Ren, Wanqing Wen, et al.. (2006). Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Breast Cancer Research and Treatment. 104(3). 309–319. 26 indexed citations
16.
Carey, Lisa A., Charles M. Perou, Chad Livasy, et al.. (2006). Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA. 295(21). 2492–2492. 2986 indexed citations breakdown →
17.
Jackson, Susan, Elizabeth Mahanna, Dianne Mattingly, et al.. (2002). Making epidemiologic studies responsive to the needs of participants and communities: The Carolina Breast Cancer Study experience. Environmental and Molecular Mutagenesis. 39(2-3). 96–101. 13 indexed citations
18.
Liao, D. Joshua, et al.. (2000). Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis. Oncogene. 19(10). 1307–1317. 50 indexed citations
19.
Deming, Sandra L., Sharyl J. Nass, Robert B. Dickson, & Bruce J. Trock. (2000). C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. British Journal of Cancer. 83(12). 1688–1695. 227 indexed citations
20.
Filardo, Edward J., Sandra L. Deming, & David A. Cheresh. (1996). Regulation of cell migration by the integrin β subunit ectodomain. Journal of Cell Science. 109(6). 1615–1622. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026